Effects of lifestyle modification on coronary artery calcium progression and prognostic factors in coronary patients-3-Year results of the randomized SAFE-LIFE trial

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 630-636

  Lehmann, Nils ^a   Paul, Anna ^b   Moebus, Susanne ^a   Budde, Thomas ^c   Dobos, Gustav J ^b   Michalsen, Andreas ^d,e  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

^c ALFRIED KRUPP KRANKENHAUS   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Immanuel Hospital Berlin   (Germany)

Author keywords

Chronic ischemic heart disease; Coronary artery calcium; Coronary artery disease; Lifestyle modification; Psychosocial factors; Stress reduction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; WARFARIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ANGINA PECTORIS; ANXIETY; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CALCIUM; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG USE; ELECTRON BEAM TOMOGRAPHY; ENERGY EXPENDITURE; EXERCISE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART RATE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDITERRANEAN DIET; MENTAL STRESS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SELF REPORT; STRESS MANAGEMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WRITTEN LANGUAGE;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIET, MEDITERRANEAN; DISEASE PROGRESSION; FEMALE; GERMANY; HEART RATE; HUMANS; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; MIND-BODY THERAPIES; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 82955235614     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.050     Document Type: Article

References (36)

1. Ornish D., Brown S.E., Scherwitz L.W., et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990, 336:129-133.
2. Schuler G., Hambrecht R., Schlierf G., et al. Regular physical exercise and low fat diet: effects on progression of coronary artery disease. Circulation 1992, 86:1-11.
3. Kotseva K., Wood D., De Backer G., et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009, 16:121-137.
4. Lear S.A., Ignaszewski A., Linden W., et al. The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J 2003, 24:1920-1927.
5. Willich S.N., Muller-Nordhorn J., Kulig M., et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. Eur Heart J 2001, 22:307-313.
6. Giannuzzi P., Temporelli P.L., Marchioli R., et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008, 168:2194-2204.
7. Wood D.A., Kotseva K., Connolly S., et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008, 371:1999-2012.
8. Michalsen A., Knoblauch N.T., Lehmann N., et al. Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina - the role of GNB3 C825T polymorphism. Am Heart J 2006, 151:870-877.
9. Hautzinger M. The Beck Depression Inventory in clinical practice. Nervenarzt 1991, 62:689-696.
10. Spielberger C., Gorsuch R., Lushene R. STAI manual for the state-trait-anxiety-inventory 1970, Consulting Psychologist Press, Palo Alto.
11. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24:385-396.
12. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
13. Michalsen A., Grossman P., Lehmann N., et al. Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychother Psychosom 2005, 74:344-352.
14. Richardson M.T., Leon A.S., Jacobs D.R., Ainsworth B.E., Serfass R. Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994, 47:271-281.
15. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. Am Heart J 2011, 161:538-543.
16. Estruch R., Martinez-Gonzalez M.A., Corella D., et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.
17. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999, 34:253-260.
18. Anderson J.W., Liu C., Kryscio R.J. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens 2008, 21:310-316.
19. Mozaffarian D., Geelen A., Brouwer I.A., et al. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945-1952.
20. Blumenthal J.A., Sherwood A., Babyak M.A., et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA 2005, 293:1626-1634.
21. O'Rourke R.A., Brundage B.H., Froelicher V.F., et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000, 36:326-340.
22. Erbel R., Mohlenkamp S., Moebus S., et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010, 56:1397-1406.
23. Mohlenkamp S., Lehmann N., Schmermund A., et al. Prognostic value of extensive coronary calcium quantities in symptomatic males - a 5-year follow-up study. Eur Heart J 2003, 24:845-854.
24. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000, 101:850-855.
25. McCullough P.A., Chinnaiyan K.M. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med 2009, 169:2064-2070.
26. Raggi P., Davidson M., Callister T.Q., et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005, 112:563-571.
27. Schmermund A., Achenbach S., Budde T., et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006, 113:427-437.
28. O'Malley P.G. A double take on serial measurement of coronary artery calcification. Arch Intern Med 2009, 169:2051-2052.
29. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995, 92:2157-2162.
30. Berry J.D., Liu K., Folsom A.R., et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009, 119:382-389.
31. Schoenhagen P., Tuzcu E.M. Coronary artery calcification end-stage renal disease: vascular biology clinical F implications. Cleve Clin J Med 2002, 69(Suppl. 3):S12-S20.
32. Nicholls S.J., Tuzcu E.M., Wolski K., et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol 2007, 49:263-270.
33. Diez Roux A.V., Ranjit N., Powell L., et al. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. Ann Intern Med 2006, 144:822-831.
34. Tiemeier H., van Dijck W., Hofman A., et al. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry 2004, 61:369-376.
35. Hamer M., O'Donnell K., Lahiri A., Steptoe A. Salivary cortisol responses to mental stress are associated with coronary artery calcification in healthy men and women. Eur Heart J 2010, 31:424-429.
36. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005, 45:637-651.